Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study.
暂无分享，去创建一个
E. Van Cutsem | J. Tabernero | M. Fakih | F. Ciardiello | I. Bondarenko | L. Wyrwicz | G. Prager | J. Taieb | N. Amellal | Z. Pápai | D. Stroyakovskiy | C. Cremolini | K. Benhadji | R. Fougeray | D. Modest | G. Liposits | F. Cruz | C. Leger | E. Élez | P. Poureau